≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Drug-induced osteoporosis with pathological fracture

EFO MESH Endpoint Browser PheWeb

OSTPOPATFRACTURE

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — M80.4#
  • Cause of death: ICD-10 — M80.4#

2 out of 7 registries used, show all original rules.

506

4. Check minimum number of events

None

506

5. Include endpoints

None

506

6. Filter based on genotype QC (FinnGen only)

506

Control definitions (FinnGen only)

Control exclude
OSTEOPOROSIS_FRACTURE_FG

Extra metadata

First used in FinnGen datafreeze
DF2
Parent code in ICD-10
M80
Name in latin
Osteoporosis e medicamento cum fractura pathologica

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 2573 1758 796
Only index persons 2250 1568 682
Unadjusted period prevalence (%)
Whole population 0.04 0.05 0.02
Only index persons 0.05 0.06 0.03
Median age at first event (years)
Whole population 70.33 71.59 67.62
Only index persons 70.23 71.36 67.63

-FinnGen-

Key figures

All Female Male
Number of individuals 506 352 154
Unadjusted period prevalence (%) 0.10 0.12 0.07
Median age at first event (years) 68.37 68.27 68.61

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
442
Matched controls
4418
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
M80.4
ICD-10 Finland
Drug-induced osteoporosis with pathological fracture
+∞
323.0
442
*
318
Kela drug reimbursment
Teriparatide
557.3
184.3
171
5
H05AA02
ATC
teriparatide; parenteral
484.6
167.3
157
5
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
18.6
136.8
389
1251
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
20.9
127.8
205
175
M05BX04
ATC
denosumab; parenteral
23.0
119.6
182
130
H02AB06
ATC
prednisolone; systemic
11.6
101.1
379
1504
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
12.7
96.9
196
261
M05BA04
ATC
alendronic acid; oral
12.2
94.7
196
271
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
32.7
86.5
115
47
L04AX01
ATC
azathioprine; systemic
20.3
80.5
125
84
M80.9
ICD-10 Finland
Unspecified osteoporosis with pathological fracture
31.2
77.5
104
43
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
9.1
74.1
181
314
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
9.8
67.6
152
224
P01BA02
ATC
hydroxychloroquine; oral
9.6
63.2
143
210
M80.0
ICD-10 Finland
Postmenopausal osteoporosis with pathological fracture
50.3
60.1
72
17
N02AA05
ATC
oxycodone; systemic
7.0
58.3
170
363
M81.9
ICD-10 Finland
Osteoporosis, unspecified
12.0
56.6
110
119
H05BA01
ATC
calcitonin (salmon synthetic); nasal, parenteral
16.3
54.7
91
69
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
6.8
54.5
161
345
GD1AA
NOMESCO Finland
Thorax X-ray examination
5.1
53.7
324
1549
H02AB07
ATC
prednisone; oral
5.7
49.1
170
436
S32.0
ICD-10 Finland
Fracture of lumbar vertebra
14.8
48.0
83
68
M81.4
ICD-10 Finland
Drug-induced osteoporosis
68.0
47.5
54
9
J18.9
ICD-10 Finland
Pneumonia, unspecified
4.9
47.1
202
652
L95
ICPC
Osteoporosis
12.8
47.0
87
83
M05.8
ICD-10 Finland
Other seropositive rheumatoid arthritis
9.5
46.9
103
137
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
9.3
46.3
103
140
C03CA01
ATC
furosemide; systemic
4.4
45.9
238
920
H02AB09
ATC
hydrocortisone; systemic
27.0
45.6
63
27
N02AX02
ATC
tramadol; systemic, rectal
4.2
43.6
291
1396
J01MA12
ATC
levofloxacin; systemic
4.8
42.8
177
538
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
7.6
41.9
106
175
L04AA06
ATC
mycophenolic acid; systemic
23.7
41.8
60
29
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
9.6
41.3
89
113
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
4.0
40.4
239
1004
M05BA07
ATC
risedronic acid; oral
11.0
39.7
79
86
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
4.8
39.7
162
479
L01BA01
ATC
methotrexate; systemic (folic acid analog.)
10.4
39.1
80
92
H02AB04
ATC
methylprednisolone; systemic
4.9
38.6
149
414
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
3.8
37.5
229
971
ZX120
NOMESCO Finland
Intravenous
6.0
36.3
111
234
TPH04
NOMESCO Finland
Cathetrisation of vein
4.1
35.4
173
597
R50.9
ICD-10 Finland
Fever, unspecified
4.8
33.4
127
340
E27.3
ICD-10 Finland
Drug-induced adrenocortical insufficiency
177.8
32.1
33
*
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
4.5
31.7
131
379
M54.5
ICD-10 Finland
Low back pain
3.4
31.4
217
974
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
4.6
31.1
123
340
A49.9
ICD-10 Finland
Bacterial infection, unspecified
4.9
30.1
109
274
L04AA13
ATC
leflunomide; oral
13.2
29.8
53
45
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
5.6
29.8
94
202
A02BC02
ATC
pantoprazole; systemic
3.7
29.6
358
2377
M80.8
ICD-10 Finland
Other osteoporosis with pathological fracture
61.1
29.6
34
6
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
3.2
29.4
244
1231
J45.9
ICD-10 Finland
Asthma, unspecified
3.9
29.2
145
493
UGC12
NOMESCO Finland
Flexible bronchoscopy
6.3
28.7
82
155
SPAT1148
SPAT
Treatment of chronic ulcer or burn
4.1
28.1
126
389
N03AX16
ATC
pregabalin; oral
3.4
27.5
175
719
M06.9
ICD-10 Finland
Rheumatoid arthritis, unspecified
11.9
27.3
51
48
R03BB04
ATC
tiotropium bromide; inhalant
5.1
27.1
94
224
X59
ICD-10 Finland
Exposure to unspecified factor
3.8
27.0
137
470
A07EC01
ATC
sulfasalazine; oral, rectal
5.4
26.7
87
193
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
3.6
25.8
144
529
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
4.8
25.4
93
233
M05BB03
ATC
alendronic acid and colecalciferol; oral
9.2
25.2
54
66
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
9.2
25.2
54
66
L88
ICPC
Rheumatoid/seropositive arthritis
7.4
25.2
62
95
J01FF01
ATC
clindamycin; systemic
3.1
25.0
183
816
L04AD01
ATC
ciclosporin; systemic
14.4
24.8
42
32
SPAT1254
SPAT
Administration of medicine
3.7
24.7
129
447
127
Kela drug reimbursment
Transplant complication
17.0
24.6
39
25
J45.0
ICD-10 Finland
Predominantly allergic asthma
5.1
24.5
83
191
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
10.3
24.5
49
53
L03
ICPC
Low back symptom/complaint
3.2
24.5
171
737
S22.0
ICD-10 Finland
Fracture of thoracic vertebra
13.9
24.4
42
33
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
4.4
24.4
97
264
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
6.7
24.1
64
109
L28
ICPC
Limited function/disability (L)
3.5
24.0
135
495
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
4.1
24.0
104
307
A46
ICD-10 Finland
Erysipelas
3.9
23.9
111
348
J01MA14
ATC
moxifloxacin; systemic
4.8
23.9
87
216
R03AK06
ATC
salmeterol and fluticasone; inhalant
3.9
23.9
113
360
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
5.2
23.7
79
178
NF1AA
NOMESCO Finland
Hip X-ray examination
4.4
23.5
94
257
XG410
NOMESCO Finland
Flow-volume spirometry
8.1
23.3
54
75
B01AB05
ATC
enoxaparin; parenteral
2.9
23.1
206
1033
A28
ICPC
Limited function/disability NOS
3.4
23.0
132
490
SPAT1216
SPAT
Assessment of functional ability
3.4
22.9
130
478
J45.1
ICD-10 Finland
Nonallergic asthma
5.3
22.8
74
162
TGC00
NOMESCO Finland
Bronchial lavation
12.8
22.5
40
34
UJF32
NOMESCO Finland
Coloscopy
2.9
22.4
182
859
SPAT1255
SPAT
Intravenous administration of medicine
5.6
22.3
68
138
SPAT1229
SPAT
Assessment of need for aid
4.6
22.2
84
216
S97
ICPC
Chronic ulcer skin
5.7
22.1
67
135
J01MA02
ATC
ciprofloxacin; systemic
2.7
22.1
235
1303
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
4.6
21.6
81
206
313
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)
11.2
21.6
41
40
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
6.0
21.2
61
115
NA7EA
NOMESCO Finland
Scoliosis X-ray examination
19.0
21.2
32
18
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
3.3
21.1
129
496
M35.3
ICD-10 Finland
Polymyalgia rheumatica
6.8
21.1
55
91
SPAT1262
SPAT
Handing over of treatment supplies
3.2
21.0
132
518
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
3.5
20.8
110
379
GD1AD
NOMESCO Finland
Thorax CT examination
7.5
20.7
50
74
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
7.0
20.6
52
82
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
4.7
20.6
75
185
M05.9
ICD-10 Finland
Seropositive rheumatoid arthritis, unspecified
9.2
20.4
43
51
S81.8
ICD-10 Finland
Open wound of other parts of lower leg
7.5
20.4
49
72
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
2.6
20.3
208
1110
A07AA02
ATC
nystatin; oral
4.9
20.1
69
160
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
3.1
19.6
131
531
M79.6
ICD-10 Finland
Pain in limb
2.6
19.6
210
1141
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
2.9
19.5
147
647
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
5.7
19.5
58
114
H26.3
ICD-10 Finland
Drug-induced cataract
33.0
19.5
25
8
N03AX12
ATC
gabapentin; oral
3.2
19.3
116
437
NA3AD
NOMESCO Finland
Lumbar spine and sacrum CT examination
8.0
19.2
44
60
R06.0
ICD-10 Finland
Dyspnoea
2.7
19.0
169
823
M84.3
ICD-10 Finland
Stress fracture, not elsewhere classified
29.3
18.9
25
9
J01DB01
ATC
cefalexin; oral
3.4
18.9
391
3069
X58
ICD-10 Finland
Exposure to other specified factors
3.6
18.7
95
316
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
4.1
18.7
77
214
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
3.9
18.5
83
249
WX408
NOMESCO Finland
General anesthesy, balanced
2.7
18.4
169
833
A06AD11
ATC
lactulose; oral
3.3
18.4
105
381
M06.0
ICD-10 Finland
Seronegative rheumatoid arthritis
7.7
18.3
43
61
J46
ICD-10 Finland
Status asthmaticus
7.8
18.0
42
59
A02BC05
ATC
esomeprazole; systemic
2.4
17.9
232
1375
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
2.4
17.9
245
1497
SPAT1256
SPAT
Intramuscular and subcutaneous injection
2.4
17.7
243
1483
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
2.5
17.6
185
978
E0000UV
ATC
NA
2.4
17.6
222
1292
J84.1
ICD-10 Finland
Other interstitial pulmonary diseases with fibrosis
12.7
17.6
31
26
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
6.1
17.5
49
89
281
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab
9.9
17.5
35
38
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
4.1
17.4
71
195
L76
ICPC
Fracture: other
7.5
17.3
41
59
N02AJ06
ATC
codeine and paracetamol; systemic
2.4
17.2
202
1133
ZX108
NOMESCO Finland
Inhalation
18.3
17.1
26
15
M81.8
ICD-10 Finland
Other osteoporosis
18.3
17.1
26
15
M35.9
ICD-10 Finland
Systemic involvement of connective tissue, unspecified
18.3
17.1
26
15
SPAT1263
SPAT
Sampling
2.4
16.8
233
1414
NE1AA
NOMESCO Finland
Pelvis X-ray examination
4.2
16.8
68
185
E27.4
ICD-10 Finland
Other and unspecified adrenocortical insufficiency
+∞
16.8
16
*
A41.9
ICD-10 Finland
Sepsis, unspecified
7.1
16.6
41
63
M01CB01
ATC
sodium aurothiomalate; parenteral
11.0
16.5
31
30
NA1EA
NOMESCO Finland
Cervical spine X-ray examination with flexion
11.0
16.5
31
30
M48.0
ICD-10 Finland
Spinal stenosis
3.1
16.3
101
385
WX002
NOMESCO Finland
Sedation and analgesia
2.7
16.2
133
607
WZB00
NOMESCO Finland
Telephone receipt or other advice
2.6
16.2
150
734
J84.9
ICD-10 Finland
Interstitial pulmonary disease, unspecified
11.4
16.2
30
28
M32.9
ICD-10 Finland
Systemic lupus erythematosus, unspecified
25.6
16.2
22
9
WZC30
NOMESCO Finland
Teaching
3.2
15.9
95
351
C07AB07
ATC
bisoprolol; oral
2.3
15.9
262
1713
Z94.4
ICD-10 Finland
Liver transplant status
27.4
15.7
21
8
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
4.4
15.6
58
145
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
5.8
15.6
45
85
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
4.2
15.5
61
161
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.4
15.3
182
1007
M05BA06
ATC
ibandronic acid; systemic
7.2
15.3
37
55
J45.8
ICD-10 Finland
Mixed asthma
7.2
15.3
37
55
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
5.2
15.2
48
101
L04AA01
ATC
[U] ciclosporin; systemic
10.0
15.2
30
32
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
3.7
15.2
69
208
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
4.9
15.1
50
111
Z01.8
ICD-10 Finland
Other specified special examinations
2.6
15.0
132
622
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
3.1
15.0
94
358
SPAT1295
SPAT
Other function in accordance with physical therapy nomenclature
4.5
14.9
54
132
NK6PA
NOMESCO Finland
Measurement of bone density from one location with X-ray
58.7
14.9
17
*
I50.9
ICD-10 Finland
Heart failure, unspecified
3.1
14.9
91
343
R03AL02
ATC
salbutamol and ipratropium bromide; inhalant
14.8
14.7
24
17
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
2.2
14.7
248
1613
R03AK04
ATC
salbutamol and sodium cromoglicate; inhalant
16.1
14.6
23
15
M13.9
ICD-10 Finland
Arthritis, unspecified
4.3
14.5
55
140
JJC00
NOMESCO Finland
Allogenic transplantation of liver
37.4
14.5
18
5
AA1AD
NOMESCO Finland
CT of head and brain
2.4
14.5
155
806
M05BA01
ATC
etidronic acid; systemic
17.7
14.4
22
13
D64.9
ICD-10 Finland
Anaemia, unspecified
3.4
14.4
75
252
SPAT1222
SPAT
Counselling/guidance promoting independent living
2.7
14.3
109
470
R03DA04
ATC
theophylline; systemic, rectal
4.6
14.3
50
118
J44.9
ICD-10 Finland
Chronic obstructive pulmonary disease, unspecified
6.2
14.1
38
66
C03DA01
ATC
spironolactone; oral
3.2
14.1
79
280
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
4.1
14.1
57
155
S22.3
ICD-10 Finland
Fracture of rib
4.1
14.0
56
150
NH3BA
NOMESCO Finland
Foot and toes extensive X-ray examination
5.6
14.0
41
79
WX892
NOMESCO Finland
Monitored bed care
4.0
14.0
57
156
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
4.0
14.0
57
156
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
4.9
13.9
46
102
M54.9
ICD-10 Finland
Dorsalgia, unspecified
3.3
13.9
76
263
A07AA09
ATC
vancomycin; oral
14.2
13.9
23
17
M35.0
ICD-10 Finland
Sicca syndrome [Sjögren]
7.6
13.8
32
45
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
5.5
13.7
41
81
R03AC02
ATC
salbutamol; inhalant
2.2
13.7
261
1765
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
7.9
13.7
31
42
A05AA02
ATC
ursodeoxycholic acid; oral
11.4
13.7
25
23
A02BA02
ATC
ranitidine; systemic
2.5
13.6
124
590
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.7
13.6
106
464
B01AA03
ATC
warfarin; systemic
2.5
13.6
124
592
N02BE01
ATC
paracetamol; systemic, rectal
3.2
13.6
404
3403
R03AC03
ATC
terbutaline; inhalant
2.9
13.5
90
355
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
4.5
13.5
49
120
M25.5
ICD-10 Finland
Pain in joint
2.3
13.5
151
802
M80.5
ICD-10 Finland
Idiopathic osteoporosis with pathological fracture
22.0
13.4
19
9
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
5.5
13.4
40
79
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
3.7
13.4
61
184
NF3AA
NOMESCO Finland
Femur X-ray examination
8.3
13.3
29
37
R03BA05
ATC
fluticasone; inhalant
2.6
13.3
112
513
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
2.6
13.2
111
505
J01FA06
ATC
roxithromycin; oral
2.1
13.2
214
1343
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
4.2
13.2
51
133
QDB05
NOMESCO Finland
Revision of wound of skin of lower limb
7.3
13.1
31
45
L04AB01
ATC
etanercept; parenteral
13.5
13.0
22
17
L89
ICD-10 Finland
Decubitus ulcer and pressure area
13.5
13.0
22
17
S18
ICPC
Laceration/cut
2.1
13.0
226
1459
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
4.4
13.0
47
115
NH3DA
NOMESCO Finland
Bilateral foot X-ray examination
7.2
12.9
31
46
A07EC02
ATC
mesalazine; oral, rectal
4.9
12.9
42
92
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
2.1
12.9
243
1622
M54.6
ICD-10 Finland
Pain in thoracic spine
3.9
12.8
54
152
SPAT1149
SPAT
Suture or treatment of traumatic wound
2.8
12.8
88
356
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
2.8
12.8
88
356
XF400
NOMESCO Finland
ECG with 12 standard connections
2.7
12.8
101
443
L29
ICPC
Musculoskeletal sympt/complt other
3.8
12.8
55
158
R03BB01
ATC
ipratropium bromide; inhalant
4.9
12.7
42
93
W19
ICD-10 Finland
Unspecified fall
3.4
12.7
65
215
A07EA06
ATC
budesonide; oral, local oral
5.9
12.7
35
63
7140A
ICD-9 Finland
Rheumatoid arthritis and other inflammatory polyarthropathies, Rheumatoid arthritis[ARTHRITIS RHEUMATOIDES SEROPOSITIVA]
9.1
12.7
26
30
M80
ICD-10 Finland
Osteoporosis with pathological fracture
11.5
12.7
23
21
R60.0
ICD-10 Finland
Localized oedema
2.9
12.7
82
317
R4110
NOMESCO Finland
Physiotherapy
2.3
12.7
151
821
PAW37
NOMESCO Finland
Biopsy of temporal artery
33.1
12.6
16
5
SPAT1215
SPAT
Assessment of need for medical rehabilitation
4.8
12.6
42
94
TPH07
NOMESCO Finland
Cathetrisation of artery
3.2
12.6
69
238
WX872
NOMESCO Finland
Intensive care
5.2
12.5
39
81
JN4BD
NOMESCO Finland
Extensive body CT
2.9
12.4
82
323
R03AC13
ATC
formoterol; inhalant
4.3
12.4
47
120
UJF30
NOMESCO Finland
Ileoscopy through colon
3.2
12.4
68
235
ND1AA
NOMESCO Finland
Wrist X-ray examination
3.6
12.3
57
174
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
4.3
12.3
46
116
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.9
12.3
81
318
M05BX03
ATC
strontium ranelate; oral
16.5
12.2
19
12
L04AD02
ATC
tacrolimus; systemic (calcineurin inhibitors)
16.5
12.2
19
12
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
12.9
12.2
21
17
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
7.6
12.2
28
39
NHG76
NOMESCO Finland
Arthroplasty of other tarsometatarsal joint
7.6
12.2
28
39
TQW40
NOMESCO Finland
Remowal of suture of skin
3.6
12.1
57
176
L04AB04
ATC
adalimumab; parenteral
10.5
12.1
23
23
R03AC12
ATC
salmeterol; inhalant
4.5
12.1
43
103
L01BB02
ATC
mercaptopurine; oral
27.6
12.1
16
6
XW000
NOMESCO Finland
Bone marrow biopsy
4.8
12.1
40
89
N06AX21
ATC
duloxetine; oral
3.0
12.1
72
265
NC1AA
NOMESCO Finland
Elbow X-ray examination without contrast
6.5
12.0
31
51
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
4.6
12.0
42
99
ZXA00
NOMESCO Finland
Right side
2.2
12.0
160
911
R07.4
ICD-10 Finland
Chest pain, unspecified
2.2
12.0
155
869
A03FA01
ATC
metoclopramide; systemic, rectal
2.4
11.8
122
615
J44.0
ICD-10 Finland
Chronic obstructive pulmonary disease with acute lower respiratory infection
4.8
11.8
39
87
SAA03
NOMESCO Finland
Extended examination of mouth
2.1
11.8
180
1088
J96.1
ICD-10 Finland
Chronic respiratory failure
7.5
11.7
27
38
5BA08
NOMESCO Finland
NA
19.6
11.7
17
9
WX110
NOMESCO Finland
Local anesthesy
2.1
11.6
310
2339
SAA02
NOMESCO Finland
Basic examination of mouth
2.0
11.6
277
1997
XF600
NOMESCO Finland
Bloodpressure measurement
3.9
11.5
48
134
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
3.0
11.5
70
261
P01AB01
ATC
metronidazole; oral, rectal
2.0
11.5
199
1262
M87.1
ICD-10 Finland
Osteonecrosis due to drugs
123.0
11.5
12
*
TQW99
NOMESCO Finland
Other minor procedure on skin
4.2
11.5
44
114
NH3EA
NOMESCO Finland
Feet X-ray examination with load
7.6
11.4
26
36
WW500
NOMESCO Finland
Blood transfusion
4.9
11.4
37
81
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.1
11.2
178
1086
K83.0
ICD-10 Finland
Cholangitis
13.2
11.2
19
15
R70.0
ICD-10 Finland
Elevated erythrocyte sedimentation rate
8.4
11.2
24
30
WX882
NOMESCO Finland
High dependency care
7.4
11.2
26
37
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
3.4
11.2
56
182
J47
ICD-10 Finland
Bronchiectasis
6.9
11.1
27
41
Z01.0
ICD-10 Finland
Examination of eyes and vision
2.5
11.1
94
426
R11
ICD-10 Finland
Nausea and vomiting
3.4
11.1
56
183
UDQ12
NOMESCO Finland
Flexible laryngoscopy
4.3
11.0
41
103
R03AK03
ATC
[D] fenoterol & other drugs for obstructive airway dis; inhalant
4.2
11.0
42
108
208
Kela drug reimbursment
Ulcerative colitis and Crohn's disease
5.5
11.0
32
62
SPAT1231
SPAT
Assessment of adjustments needed in living environment
6.8
11.0
27
42
WW200
NOMESCO Finland
Immunization
6.4
10.9
28
46
J44.1
ICD-10 Finland
Chronic obstructive pulmonary disease with acute exacerbation, unspecified
5.9
10.9
30
54
N06AA09
ATC
amitriptyline; systemic
2.8
10.9
76
308
K50.9
ICD-10 Finland
Crohn disease, unspecified
10.0
10.9
21
22
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
4.3
10.8
40
100
R03DC03
ATC
montelukast; oral
2.5
10.8
95
440
TNX33
NOMESCO Finland
Custom moulded cast, unspecified region
3.7
10.7
47
137
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
4.7
10.7
36
82
TPX10
NOMESCO Finland
Implantation of vascular injection port
6.8
10.7
26
40
J01.0
ICD-10 Finland
Acute maxillary sinusitis
2.3
10.6
115
590
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
2.5
10.5
93
430
SPAT1211
SPAT
Application of soft bandage
3.0
10.5
63
231
N05CF01
ATC
zopiclone; oral
2.0
10.4
178
1110
K02.1
ICD-10 Finland
Caries of dentine
1.9
10.4
243
1707
K08.3
ICD-10 Finland
Retained dental root
3.6
10.4
47
141
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
9.9
10.4
20
21
R03BA02
ATC
budesonide; inhalant
2.4
10.4
99
478
TNX32
NOMESCO Finland
Custom moulded splint, unspecified region
4.0
10.3
41
110
ND2DA
NOMESCO Finland
Bilateral hand X-ray examination
6.2
10.3
27
46
R03DC01
ATC
zafirlukast; oral
8.2
10.2
22
28
TQW11
NOMESCO Finland
Vacuum treatment of wound
6.7
10.2
25
39
JN3AD
NOMESCO Finland
Abdominal CT examination
3.2
10.1
53
178
K50.1
ICD-10 Finland
Crohn disease of large intestine
11.7
10.1
18
16
L02
ICPC
Back symptom/complaint
3.1
10.1
57
201
SPAT1325
SPAT
Vaccination
2.0
10.1
188
1207
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
4.1
10.1
39
102
R4120
NOMESCO Finland
Occupational therapy
3.6
10.1
46
139
JJ9AE
NOMESCO Finland
Ultrasound examination of liver transplant
41.0
10.0
12
*
NA2BG
NOMESCO Finland
Thoracal spine MRI examination with high intensity magnet
5.9
10.0
27
48
JN4AD
NOMESCO Finland
Body CT examination
3.2
9.9
53
181
A01AB09
ATC
miconazole; local oral
2.8
9.9
65
254
R03AK08
ATC
formoterol and beclometasone; inhalant
4.8
9.9
32
70
R60.9
ICD-10 Finland
Oedema, unspecified
3.9
9.9
40
109
J20
ICD-10 Finland
Acute bronchitis
3.1
9.9
56
199
UJF92
NOMESCO Finland
Capsular endoscopy
7.7
9.8
22
30
J05AB11
ATC
valaciclovir; oral
2.5
9.7
79
351
WX725
NOMESCO Finland
Noninvasive ventilation
4.2
9.7
36
91
L98.9
ICD-10 Finland
Disorder of skin and subcutaneous tissue, unspecified
10.4
9.6
18
18
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
4.0
9.5
37
98
K04.5
ICD-10 Finland
Chronic apical periodontitis
2.1
9.4
122
674
R01AD08
ATC
fluticasone; nasal
2.0
9.4
137
795
R52.9
ICD-10 Finland
Pain, unspecified
2.9
9.4
59
224
SFA30
NOMESCO Finland
Filling on tree or more surfaces of tooth
1.9
9.4
187
1220
DM1AD
NOMESCO Finland
CT of paranasal sinuses and face area
5.3
9.4
28
56
M70.2
ICD-10 Finland
Olecranon bursitis
5.7
9.4
26
48
UKC02
NOMESCO Finland
Cystoscopy
2.3
9.3
90
436
A02BC01
ATC
omeprazole; systemic
2.0
9.2
142
842
SPAT1234
SPAT
Support of social functional capacity
3.5
9.2
42
127
I83.0
ICD-10 Finland
Varicose veins of lower extremities with ulcer
5.6
9.2
26
49
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
3.3
9.2
46
150
M05
ICD-10 Finland
Seropositive rheumatoid arthritis
11.8
9.1
16
14
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
5.3
9.1
27
54
I80.3
ICD-10 Finland
Phlebitis and thrombophlebitis of lower extremities, unspecified
4.4
9.1
32
77
R03AK07
ATC
formoterol and budesonide; inhalant
2.2
9.1
97
492
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
3.1
9.0
50
174
WZA90
NOMESCO Finland
Other doctors statement
2.1
9.0
115
630
L02.4
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of limb
5.2
9.0
27
55
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
12.9
8.9
15
12
XQ858
NOMESCO Finland
Oxygen partial pressure measurement
8.9
8.9
18
21
Z01.2
ICD-10 Finland
Dental examination
1.9
8.8
183
1207
SFA10
NOMESCO Finland
Fillning on one surface of tooth
1.8
8.8
228
1620
X50
ICD-10 Finland
Overexertion and strenuous or repetitive movements
7.4
8.8
20
28
SAA04
NOMESCO Finland
Special inverstigation of mouth
3.7
8.8
38
110
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
3.1
8.8
49
171
R53
ICD-10 Finland
Malaise and fatigue
2.1
8.8
105
560
M32.8
ICD-10 Finland
Other forms of systemic lupus erythematosus
51.0
8.7
10
*
J84.8
ICD-10 Finland
Other specified interstitial pulmonary diseases
8.5
8.7
18
22
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
3.2
8.6
46
157
R1250
NOMESCO Finland
Evaluation of functional capability
7.2
8.6
20
29
Z96.1
ICD-10 Finland
Presence of intraocular lens
2.3
8.6
82
393
A02BC03
ATC
lansoprazole; oral
1.9
8.6
158
994
NA1BA
NOMESCO Finland
Cervical spine extensive X-ray examination without contrast
11.9
8.6
15
13
R06AE07
ATC
cetirizine; oral
1.8
8.6
199
1359
RS220
NOMESCO Finland
NA
9.3
8.6
17
19
71238
ICD-8 Finland
Rheumatoid arthritis and allied conditions, Arthritis rheumatoides alia definita
10.3
8.6
16
16
49300
ICD-8 Finland
Asthma, bronchiale
5.6
8.6
24
45
FM1BE
NOMESCO Finland
Cardiac ultrasound examination through oesophagus
3.4
8.6
40
124
N05BA01
ATC
diazepam; systemic, rectal
2.4
8.6
79
373
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.9
8.5
150
930
J02AC01
ATC
fluconazole; systemic
1.8
8.5
193
1308
K44.9
ICD-10 Finland
Diaphragmatic hernia without obstruction or gangrene
2.9
8.5
53
201
R03AL01
ATC
fenoterol and ipratropium bromide; inhalant
5.2
8.5
25
50
A01
ICPC
Pain general/multiple sites
2.8
8.4
53
202
ZZH31
NOMESCO Finland
Bone allograft, small pieces
13.1
8.4
14
11
EB1AA
NOMESCO Finland
Tooth X-ray examination
1.8
8.4
235
1705
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
3.4
8.4
40
126
NA1AD
NOMESCO Finland
Cervical spine CT examination
4.4
8.4
29
69
E23.03
ICD-10 Finland
Lack of ACTH
+∞
8.4
8
*
M31.5
ICD-10 Finland
Giant cell arteritis with polymyalgia rheumatica
11.0
8.3
15
14
N03AX09
ATC
lamotrigine; oral
4.7
8.3
27
60
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
2.4
8.3
72
327
EBA10
NOMESCO Finland
Surgical removal of tooth
2.7
8.3
56
223
D50.0
ICD-10 Finland
Iron deficiency anaemia secondary to blood loss (chronic)
4.5
8.3
28
65
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
2.8
8.3
52
198
WX290
NOMESCO Finland
Other blockade of nerve
1.9
8.3
172
1130
NG4AA
NOMESCO Finland
Lower leg X-ray examination
5.6
8.3
23
43
EBA15
NOMESCO Finland
Extraction of large number of teeth
4.4
8.3
29
70
QCB05
NOMESCO Finland
Revision of wound of skin of upper limb
14.8
8.2
13
9
NFJ60
NOMESCO Finland
Internal fixation of fracture of other parts of femur with intramedullary nail
14.8
8.2
13
9
J01DA01
ATC
[U] cefalexin; systemic
1.8
8.2
286
2219
H25.8
ICD-10 Finland
Other senile cataract
2.4
8.2
70
318
TDM10
NOMESCO Finland
Puncture of maxillary antrum
4.2
8.1
30
76
A11CC03
ATC
alfacalcidol; systemic
6.5
8.1
20
32
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
2.2
8.1
83
413
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
2.0
8.0
114
649
J01AA02
ATC
doxycycline; systemic
1.9
8.0
351
2936
TK800
NOMESCO Finland
Hemodialysis
5.3
8.0
23
45
ZX112
NOMESCO Finland
Subcutaneous
5.9
7.9
21
37
JN3DE
NOMESCO Finland
Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation
13.3
7.9
13
10
K51.9
ICD-10 Finland
Ulcerative colitis, unspecified
5.0
7.9
24
50
SHA03
NOMESCO Finland
Correction of physiology of bite - demanding therapy visit
5.0
7.9
24
50
TKC20
NOMESCO Finland
Catheterisation of bladder
3.0
7.9
45
161
H04.10
ICD-10 Finland
Dry eye syndrome
2.5
7.8
60
257
EB1BI
NOMESCO Finland
Cone beam imaging of teeth and jaws (1–2 quarters)
9.7
7.8
15
16
SCA02
NOMESCO Finland
Analysis and advice of nutrition with regard to dentistry
2.8
7.8
52
203
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
2.2
7.8
89
463
K50.0
ICD-10 Finland
Crohn disease of small intestine
7.6
7.7
17
23
ZXA05
NOMESCO Finland
Left side
1.9
7.7
141
879
ZZA00
NOMESCO Finland
Split skin graft
4.7
7.7
25
56
SPAT1226
SPAT
Implementation of occupational therapy rehabilitation plan
4.7
7.7
25
56
B02.9
ICD-10 Finland
Zoster without complication
3.2
7.7
40
135
SFC01
NOMESCO Finland
Adjuvant procedure of filling therapy
1.9
7.7
123
734
WX100
NOMESCO Finland
Conjunctival surface anesthesia
2.3
7.7
71
335
N30.0
ICD-10 Finland
Acute cystitis
2.2
7.7
84
429
S32.7
ICD-10 Finland
Multiple fractures of lumbar spine and pelvis
8.3
7.7
16
20
L03.1
ICD-10 Finland
Cellulitis of other parts of limb
5.3
7.7
22
43
M54.4
ICD-10 Finland
Lumbago with sciatica
2.1
7.6
90
475
M08.0
ICD-10 Finland
Juvenile rheumatoid arthritis
18.7
7.6
11
6
NDU20
NOMESCO Finland
Removal of internal fixation device from wrist or hand
5.6
7.6
21
39
L03.0
ICD-10 Finland
Cellulitis of finger and toe
3.0
7.6
43
152
E27.1
ICD-10 Finland
Primary adrenocortical insufficiency
25.5
7.6
10
*
D86.8
ICD-10 Finland
Sarcoidosis of other and combined sites
25.5
7.6
10
*
J01DA06
ATC
[U] cefuroxime; systemic
2.2
7.6
79
392
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
2.9
7.5
45
167
NH1BA
NOMESCO Finland
Ankle extensive X-ray examination
4.7
7.5
24
53
NE1AD
NOMESCO Finland
Pelvis and hip bones CT examination
5.5
7.5
21
40
N07BC02
ATC
methadone; systemic
81.4
7.4
8
*
R52.2
ICD-10 Finland
Other chronic pain
4.9
7.4
23
49
R35
ICD-10 Finland
Polyuria
3.2
7.4
38
127
TAB00
NOMESCO Finland
Lumbar puncture
3.9
7.4
29
78
H26.4
ICD-10 Finland
After-cataract
2.4
7.3
62
280
M31.9
ICD-10 Finland
Necrotizing vasculopathy, unspecified
+∞
7.3
7
*
M30.1
ICD-10 Finland
Polyarteritis with lung involvement [Churg-Strauss]
+∞
7.3
7
*
QBB10
NOMESCO Finland
Major dressing of wound of skin of trunk
4.8
7.3
23
50
R51.80
ICD-10 Finland
Headache
2.3
7.3
68
320
W00
ICD-10 Finland
Fall on same level involving ice and snow
2.4
7.2
61
274
SPAT1305
SPAT
Counselling and guidance related to physical exercise
2.5
7.2
58
253
-1
NOMESCO Finland
NA
1.8
7.2
143
913
NH1AD
NOMESCO Finland
Ankle and foot CT
5.2
7.2
21
42
QXB99
NOMESCO Finland
Other procedure to treat skin wound, unspecified location
6.8
7.2
17
26
J82
ICD-10 Finland
Pulmonary eosinophilia, not elsewhere classified
30.5
7.2
9
*
DMB20
NOMESCO Finland
Functional endoscopic opening of maxillary antrum
3.4
7.2
33
102
W22
ICD-10 Finland
Striking against or struck by other object(s)
3.4
7.2
33
102
B01AB04
ATC
dalteparin; parenteral
3.2
7.1
36
119
C08CA01
ATC
amlodipine; oral
1.8
7.1
181
1253
NHU20
NOMESCO Finland
Removal of internal fixation device from ankle or foot
3.5
7.1
32
97
TNX50
NOMESCO Finland
Removal of cutom molded cast and internal stretch
3.1
7.1
38
131
A06AH03
ATC
naloxegol; oral
12.3
7.1
12
10
L17
ICPC
Foot/toe symptom/complaint
1.9
7.1
132
824
L84
ICD-10 Finland
Corns and callosities
4.1
7.1
26
66
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.9
7.1
109
638
NA2CG
NOMESCO Finland
Thoracal spine extensive MRI examination with high intensity magnet
10.3
7.1
13
13
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.7
7.1
207
1496
J01CA04
ATC
amoxicillin; systemic
1.9
7.0
349
2955
A41.8
ICD-10 Finland
Other specified sepsis
7.7
6.9
15
20
SPAT1172
SPAT
Guidance concerning hydration
4.5
6.9
23
53
I48
ICD-10 Finland
Atrial fibrillation and flutter
1.9
6.9
114
682
SFA20
NOMESCO Finland
Filling on two surfaces of tooth
1.7
6.9
234
1755
A02BA03
ATC
famotidine; systemic
3.7
6.9
29
83
EBA05
NOMESCO Finland
Complicated extraction of tooth
2.1
6.9
87
471
M87.9
ICD-10 Finland
Osteonecrosis, unspecified
14.1
6.9
11
8
D68.8
ICD-10 Finland
Other specified coagulation defects
14.1
6.9
11
8
J22
ICD-10 Finland
Unspecified acute lower respiratory infection
3.3
6.9
33
105
M81.0
ICD-10 Finland
Postmenopausal osteoporosis
4.3
6.9
24
58
R96
ICPC
Asthma
2.6
6.9
50
205
XG466
NOMESCO Finland
Sleep oxymetry
3.9
6.9
27
73
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
3.9
6.9
27
73
S92.3
ICD-10 Finland
Fracture of metatarsal bone
3.9
6.9
27
73
XKD00
NOMESCO Finland
Uroflowmetry
2.2
6.9
71
353
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
4.0
6.9
26
68
QDG20
NOMESCO Finland
Operation for chronic ulcer or fistula of skin of lower limb
8.5
6.9
14
17
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
2.8
6.8
43
163
S81.9
ICD-10 Finland
Open wound of lower leg, part unspecified
11.2
6.8
12
11
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
4.4
6.8
23
54
SPAT1301
SPAT
No procedures
1.8
6.8
159
1070
TNC11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in elbow joint
40.7
6.8
8
*
7100A
ICD-9 Finland
Diffuse diseases of connective tissue, Systemic lupus erythematosus
40.7
6.8
8
*
E000006
ATC
NA
2.7
6.8
46
182
NA3BA
NOMESCO Finland
Lumbar spine extensive X-ray examination without contrast
17.0
6.8
10
6
D69.3
ICD-10 Finland
Idiopathic thrombocytopenic purpura
17.0
6.8
10
6
K05.18
ICD-10 Finland
Chronic gingivitis
3.2
6.8
33
107
ZXA10
NOMESCO Finland
Bilateral
1.9
6.7
103
600
ND2BA
NOMESCO Finland
Hand and fingers extensive X-ray examination
5.1
6.7
20
41
C08CA05
ATC
nifedipine; systemic
2.9
6.7
40
148
B01AB10
ATC
tinzaparin; parenteral
2.6
6.7
47
192
WZA00
NOMESCO Finland
Short statement of of health and health related matters
3.3
6.7
32
102
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
2.2
6.7
71
354
TND11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in joint, wrist or hand
6.6
6.7
16
25
DNB20
NOMESCO Finland
Endoscopic ethmoidectomy
4.7
6.7
21
46
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
3.4
6.7
31
97
71239
ICD-8 Finland
Rheumatoid arthritis and allied conditions, Arthritis rheumatoides NUD
8.0
6.7
14
18
N06AX16
ATC
venlafaxine; oral
2.2
6.6
65
316
D07AC13
ATC
mometasone; topical
1.8
6.6
131
831
J44
ICD-10 Finland
Other chronic obstructive pulmonary disease
4.9
6.6
20
42
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
1.9
6.6
116
707
JN1BG
NOMESCO Finland
MRI examination of upper part of abodmen with high intensity magnet
12.5
6.6
11
9
A08
ICPC
Swelling
3.1
6.6
35
121
Y57
ICD-10 Finland
Adverse effects in the therapeutic use of other and unspecified drugs and medicaments
4.6
6.6
21
47
E000003
ATC
NA
3.6
6.5
28
82
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
6.3
6.5
16
26
K50.8
ICD-10 Finland
Other Crohn disease
6.3
6.5
16
26
S61.9
ICD-10 Finland
Open wound of wrist and hand, part unspecified
6.3
6.5
16
26
SPAT1210
SPAT
Application of cast or individual aid
3.5
6.5
29
88
XG470
NOMESCO Finland
Measurement of diffusion capastity of the lungs
4.8
6.5
20
43
WX320
NOMESCO Finland
Spinalanesthesy
1.9
6.5
115
703
EBA00
NOMESCO Finland
Extraction of tooth
1.8
6.5
137
889
NG1AE
NOMESCO Finland
Knee joint ultrasound exmination
7.6
6.5
14
19
J99.0*M05.1
ICD-10 Finland
Rheumatoid lung disease
70.8
6.4
7
*
NAU20
NOMESCO Finland
Removal of internal fixation device from spine or neck
14.6
6.4
10
7
Y88.1
ICD-10 Finland
Sequelae of misadventures to patients during surgical and medical procedures
14.6
6.4
10
7
EB1WA
NOMESCO Finland
NA
14.6
6.4
10
7
H02AB08
ATC
triamcinolone; systemic
14.6
6.4
10
7
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.8
6.4
138
902
A07DA03
ATC
loperamide; oral
3.7
6.4
26
73
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
2.3
6.4
59
279
A06AC01
ATC
ispaghula (psylla seeds); oral
1.8
6.4
128
818
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
5.3
6.4
18
35
N05BA04
ATC
oxazepam; oral
1.8
6.4
122
768
L98.4
ICD-10 Finland
Chronic ulcer of skin, not elsewhere classified
4.7
6.4
20
44
ZXM10
NOMESCO Finland
Intraoperative use of conventional X-ray imaging
2.8
6.3
38
142
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.7
6.3
169
1176
NA6AA
NOMESCO Finland
Sacro-iliac joint X-ray examination
11.2
6.3
11
10
NA7CG
NOMESCO Finland
Spine and spinal cord extensive MRI examination with high intensity magnet
9.4
6.3
12
13
J09
ICD-10 Finland
Influenza due to identified zoonotic or pandemic influenza virus
4.4
6.3
21
49
NA1AA
NOMESCO Finland
Cervical spine X-ray examination without contrast
3.7
6.3
26
74
H25.1
ICD-10 Finland
Senile nuclear cataract
1.8
6.3
140
924
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
4.9
6.3
19
40
M08.4
ICD-10 Finland
Pauciarticular juvenile arthritis
18.3
6.3
9
5
K52.9
ICD-10 Finland
Noninfective gastroenteritis and colitis, unspecified
3.9
6.3
24
64
K03.66
ICD-10 Finland
Tooth plaque
2.8
6.3
38
143
R02
ICPC
Shortness of breath/dyspnoea
2.2
6.3
66
328
RS221
NOMESCO Finland
NA
7.2
6.3
14
20
71200
ICD-8 Finland
Rheumatoid arthritis and allied conditions, Juvenile rheumatoid arthritis
+∞
6.3
6
*
JJ5AT
NOMESCO Finland
NA
27.1
6.2
8
*
NE1DG
NOMESCO Finland
Pelvic, hip and femur very extensive MRI examination with high intensity magnet
27.1
6.2
8
*
M79.0
ICD-10 Finland
Rheumatism, unspecified
3.3
6.2
29
91
M70.6
ICD-10 Finland
Trochanteric bursitis
2.0
6.2
78
420
J01EA01
ATC
trimethoprim; systemic
1.8
6.2
132
855
WX730
NOMESCO Finland
Conventional respirator
6.4
6.2
15
24
N02AC04
ATC
dextropropoxyphene; oral
3.2
6.2
30
97
WZC05
NOMESCO Finland
Specialty-specific consultation based on referral by dentist or doctor
3.2
6.2
30
97
W10
ICD-10 Finland
Fall on and from stairs and steps
3.2
6.2
30
97
I82.9
ICD-10 Finland
Embolism and thrombosis of unspecified vein
5.9
6.2
16
28
Y88.3
ICD-10 Finland
Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
4.2
6.2
22
55
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
2.8
6.2
39
148
I50.0
ICD-10 Finland
Congestive heart failure
2.8
6.2
39
148
J05AB01
ATC
aciclovir; systemic
1.9
6.2
102
611
S20.2
ICD-10 Finland
Contusion of thorax
3.5
6.2
27
81
T79.3
ICD-10 Finland
Post-traumatic wound infection, not elsewhere classified
7.8
6.2
13
17
R03BA01
ATC
beclometasone; inhalant
2.0
6.1
77
413
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
2.2
6.1
63
311
NA2AD
NOMESCO Finland
Thoracic spine CT examination
12.7
6.1
10
8
TPH05
NOMESCO Finland
Open cannulation of peripheral vein
12.7
6.1
10
8
TNB11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in shoulder joint
12.7
6.1
10
8
1300
FHL
Esophagogastroduodenoscopy (also includes staining)
12.7
6.1
10
8
M06.8
ICD-10 Finland
Other specified rheumatoid arthritis
12.7
6.1
10
8
SPAT1167
SPAT
Insertion of urinary catheter
3.8
6.1
24
66
JN4CD
NOMESCO Finland
Very extensive body CT
3.3
6.1
29
93
Z01.9
ICD-10 Finland
Special examination, unspecified
2.8
6.1
37
140
R03AL09
ATC
formoterol, glycopyrronium bromide and beclometasone; inhalant
5.3
6.1
17
33
A07EA02
ATC
hydrocortisone; rectal
5.3
6.1
17
33
R01AD09
ATC
mometasone; nasal
1.7
6.0
192
1398
T84.0
ICD-10 Finland
Mechanical complication of internal joint prosthesis
3.3
6.0
28
88

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3003458) Phosphate [Moles/volume] in Serum or Plasma
237
557
7.12
105.66
7.3
4.8
mmol/l
1.0
1.0
0.28
221
503
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
427
1884
9.11
92.46
5.3
2.3
nmol/l
87.8
79.5
7.57
405
1647
(3020630) Protein [Mass/volume] in Serum or Plasma
188
399
6.91
91.44
1.9
2.9
g/l
63.6
66.7
4.91
162
361
(42870588) Differential panel, method unspecified - Blood
366
1425
6.67
90.26
16.2
5.6
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
167
323
7.22
88.85
4.7
2.9
g/l
8.9
10.4
3.53
162
298
(3004588) Protein electrophoresis panel - Serum or Plasma
175
368
6.74
85.36
1.7
2.5
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
420
1916
8.01
84.55
18.4
5.8
%
0.6
0.7
2.81
407
1766
(3019069) Monocytes/100 leukocytes in Blood
425
1981
8.16
82.83
19.1
6.0
%
8.7
8.7
0.06
413
1836
(3001604) Monocytes [#/volume] in Blood
437
2104
8.90
81.73
17.4
5.6
e9/l
0.6
0.6
4.86
416
1800
(3006504) Eosinophils/100 leukocytes in Blood
422
1971
7.87
81.50
18.4
5.7
%
2.3
2.8
6.12
408
1815
(3006315) Basophils [#/volume] in Blood
437
2117
8.80
80.74
17.5
5.6
e9/l
0.0
0.0
0.30
415
1816
(3019198) Lymphocytes [#/volume] in Blood
439
2146
8.90
79.97
17.7
5.7
e9/l
1.7
1.9
1.87
422
1883
(3002030) Lymphocytes/100 leukocytes in Blood
425
2019
7.90
79.83
18.8
5.9
%
22.6
27.5
15.46
412
1856
(3018010) Neutrophils/100 leukocytes in Blood
422
1993
7.73
79.76
17.4
5.6
%
63.1
57.5
15.55
411
1845
(3013115) Eosinophils [#/volume] in Blood
442
2182
9.11
79.41
18.4
5.9
e9/l
0.2
0.2
2.94
418
1904
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
453
2289
10.35
79.38
16.5
6.1
mmol/l
1.2
1.2
0.06
381
1938
(3036481) Cortisol [Moles/volume] in Serum or Plasma
177
405
6.18
78.39
3.1
2.0
nmol/l
277.4
371.3
4.35
169
371
(3028026) IgM [Mass/volume] in Serum or Plasma
139
260
6.99
75.50
2.2
1.8
g/l
1.1
1.3
0.78
130
236
(3023368) Bacteria identified in Blood by Culture
313
1197
5.23
74.68
8.3
4.1
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
217
637
5.21
71.43
3.5
1.9
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
188
494
5.46
70.50
4.4
4.0
u/l
255.6
253.4
0.04
174
464
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
158
367
5.81
67.93
3.6
3.6
ng/l
79.5
80.3
0.04
135
318
(3013650) Neutrophils [#/volume] in Blood by Automated count
453
2485
8.86
66.45
23.0
9.1
e9/l
4.9
4.1
10.12
438
2162
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
413
2118
6.17
64.68
14.7
5.3
mmol/l
1.2
1.2
0.02
396
1914
(3027945) Reticulocytes/100 erythrocytes in Blood
184
517
5.02
62.84
3.7
2.5
%
2.2
1.8
1.31
165
459
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
218
730
4.49
58.92
3.0
1.8
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
96
157
7.31
58.50
2.1
3.9
mg/l
87.7
89.0
0.01
69
127
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
96
157
7.31
58.50
2.1
3.9
mg/l
31.3
27.9
0.37
68
127
(3002179) Metamyelocytes/100 leukocytes in Blood
142
340
5.42
58.25
6.7
4.0
%
0.5
0.4
0.34
53
79
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
95
155
7.31
57.99
2.1
3.8
ratio
1.1
2.1
—
10
15
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
140
334
5.41
57.63
2.5
1.5
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
150
381
5.17
57.36
6.8
4.0
%
1.0
1.0
0.05
67
117
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
101
184
6.61
55.36
2.7
1.7
ug/l
2.0
3.6
0.44
89
162
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
273
1116
4.14
55.20
3.7
2.3
mg/l
4.0
3.3
3.23
248
954
(3023520) Reticulocytes [#/volume] in Blood
149
390
5.00
54.73
4.3
2.5
e9/l
75.6
71.3
0.64
119
308
(3021440) Promyelocytes/100 leukocytes in Blood
141
354
5.14
54.43
6.9
4.2
%
0.1
0.2
0.76
64
101
(3024561) Albumin [Mass/volume] in Serum or Plasma
382
2010
4.67
53.13
10.5
4.1
g/l
33.0
35.4
12.06
359
1870
(3020779) Urea [Moles/volume] in Serum or Plasma
138
349
5.06
52.67
12.9
6.0
mmol/l
11.3
9.5
1.08
133
329
(3012095) Magnesium [Moles/volume] in Serum or Plasma
202
707
4.09
50.09
6.8
3.1
mmol/l
0.8
0.8
1.08
189
655
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
80
127
7.29
49.82
2.6
1.4
g/l
0.2
0.2
0.35
74
119
(3024980) IgG subclass 4 [Mass/volume] in Serum
54
53
11.29
49.24
2.2
2.3
g/l
0.8
1.0
0.38
41
45
(3025159) Blasts/100 leukocytes in Blood
130
333
4.91
48.56
6.9
4.3
%
0.0
1.1
0.56
55
85
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
85
149
6.65
48.13
2.0
1.5
titre
140.0
136.0
—
7
5
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
59
70
9.41
46.88
10.5
5.1
iu/ml
179.2
613.6
—
22
9
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
113
267
5.16
46.36
7.2
3.3
mmol/l
2.2
2.1
0.05
88
202
(3007853) Bacteria identified in Skin by Aerobe culture
160
499
4.23
46.11
3.1
1.6
—
—
—
0
0
(4062490)
42
31
14.68
45.58
1.9
1.3
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
116
285
4.98
45.37
7.4
3.4
kpa
5.2
5.1
0.54
111
266
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
95
197
5.71
45.11
1.9
2.0
g/l
1.7
1.7
0.07
82
171
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
180
619
3.96
45.10
3.7
2.3
%
18.8
21.7
2.01
155
525
(3018418) pH of Serum or Plasma
294
1394
3.65
45.07
8.6
3.7
ph
7.4
7.4
0.21
92
256
(3007164) IgA [Mass/volume] in Serum or Plasma
210
805
3.75
44.76
2.1
1.5
g/l
2.8
2.5
0.31
156
465
(3009343) pH of Capillary blood
114
280
4.96
44.56
7.4
3.4
ph
7.4
7.4
0.81
19
36
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
60
78
8.59
44.29
6.5
3.9
%
60.7
58.8
0.40
60
78
(40760888) Immunoglobulin light chains.free panel - Serum
73
120
6.94
43.84
2.1
4.3
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
183
648
3.86
43.76
3.7
2.2
g/l
2.2
2.3
1.91
170
594
(3030905) Polymorphonuclear cells [#/volume] in Blood
58
75
8.61
42.97
6.2
3.4
e9/l
4.4
4.4
0.03
58
75
(3022948) Iron [Moles/volume] in Serum or Plasma
191
710
3.71
42.27
3.8
2.2
umol/l
9.9
12.5
5.95
179
647
(3011412) CD3 cells [#/volume] in Blood
40
31
13.92
42.17
2.0
1.5
e9/l
1.1
1.2
0.06
31
16
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
35
22
17.02
41.27
2.2
1.7
—
—
—
0
0
(3026782) Osmolality of Urine
217
890
3.52
41.01
4.8
2.8
mosm/kgh2o
492.5
539.1
2.70
193
761
(3037522) Nuclear Ab [Titer] in Serum
163
557
3.84
40.70
1.8
1.3
titre
902.6
497.5
1.29
46
126
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
72
126
6.50
40.61
1.9
1.5
iu/ml
0.2
0.1
0.26
17
20
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
34
21
17.28
40.42
2.1
1.6
%
14.3
7.7
1.45
17
11
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
55
72
8.45
40.29
2.3
2.4
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
394
2388
3.94
38.54
13.9
5.8
umol/l
11.7
11.2
0.18
381
2250
(3037756) Immunofixation for Serum or Plasma
66
112
6.63
38.31
1.3
1.8
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
150
511
3.75
37.27
2.5
1.7
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
67
121
6.23
36.52
2.8
1.5
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
334
1864
3.33
36.51
18.4
9.0
inr
1.3
1.2
0.61
96
527
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
86
201
4.95
35.27
1.6
2.3
g/l
3.7
3.8
0.14
58
143
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
86
202
4.92
35.05
1.6
2.3
g/l
7.7
7.8
0.12
60
149
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
86
202
4.92
35.05
1.6
2.3
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
279
1430
3.12
34.84
4.0
2.3
u/l
54.8
56.1
0.32
262
1307
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
300
1607
3.13
34.54
7.1
3.2
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
81
185
5.02
34.09
1.6
2.3
g/l
3.2
3.2
0.05
58
146
(3015377) Calcium [Moles/volume] in Serum or Plasma
300
1616
3.10
34.03
4.2
3.4
mmol/l
2.3
2.4
2.60
263
1390
(3026008) Bacteria identified in Urine by Culture
287
1514
3.07
33.70
5.6
3.3
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
67
132
5.70
33.27
6.8
2.3
u/ml
0.3
0.4
0.71
47
79
(3037467) Urinalysis macro (dipstick) panel - Urine
439
2990
4.54
33.26
10.8
4.6
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
35
32
11.68
33.22
2.5
1.6
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
72
152
5.36
33.14
3.0
3.2
g/l
0.4
0.2
0.69
29
47
(3031040) Bacteria [#/volume] in Urine by Automated count
434
2942
4.34
32.88
9.9
4.8
e6/l
3329.8
4931.4
—
5
48
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
66
130
5.69
32.77
1.4
1.7
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
207
923
3.10
32.60
1.4
1.2
u/ml
0.8
1.5
0.95
68
233
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
81
192
4.83
32.56
1.5
2.3
g/l
9.3
9.9
0.47
63
163
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
143
513
3.49
32.36
2.6
1.8
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
208
936
3.08
32.15
5.1
2.5
e6/l
4.9
5.8
0.62
193
830
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
470
3414
6.29
31.51
24.3
7.4
u/l
78.4
79.3
0.17
460
3169
(3001122) Ferritin [Mass/volume] in Serum or Plasma
310
1751
2.99
31.37
4.6
2.7
ug/l
143.9
120.7
0.78
293
1583
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
125
420
3.62
31.20
3.8
2.1
g/l
0.2
0.2
0.15
117
397
(40760892) CBC W Ordered Manual Differential panel - Blood
196
878
3.01
30.20
13.1
4.8
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
65
137
5.30
29.89
3.8
2.5
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
42
57
7.94
29.70
1.2
1.1
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
397
2619
3.39
29.61
12.4
4.4
mmol/l
6.4
6.7
2.60
388
2459
(3013707) Erythrocyte sedimentation rate by Westergren method
451
3234
4.63
29.30
14.9
4.3
mm/h
19.3
13.2
10.37
439
2957
(3023419) Bacteria identified in Sputum by Culture
41
56
7.88
28.82
3.0
2.6
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
261
1390
2.81
28.73
4.6
2.3
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
254
1338
2.80
28.50
6.7
3.2
e6/l
32.9
101.3
0.74
220
1035
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
55
104
5.81
28.43
2.1
1.7
—
—
—
0
0
(1616796) Gas panel - Central venous blood
49
83
6.43
28.31
4.9
4.1
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
116
398
3.48
27.78
1.8
1.4
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
42
62
7.30
27.58
3.3
2.8
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
46
75
6.65
27.56
2.1
1.7
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
52
97
5.86
27.24
2.1
1.7
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
223
1123
2.76
26.96
4.2
2.5
umol/l
2850.1
8658.4
1.24
193
943
(3017143) Hepatitis C virus Ab [Presence] in Serum
108
363
3.51
26.63
1.8
1.4
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
122
445
3.29
26.38
2.0
1.6
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
255
1385
2.70
26.37
3.4
2.1
u/l
101.3
204.0
4.03
238
1301
(3030467) Casts [#/volume] in Urine by Automated count
237
1242
2.71
26.33
6.6
3.1
e6/l
0.4
0.5
0.14
203
938
(3018095) Leukocytes [#/volume] in Urine
274
1552
2.67
25.88
7.9
3.8
e6/l
59.5
115.5
1.32
224
1126
(3019309) Folate [Moles/volume] in Red Blood Cells
195
933
2.77
25.83
2.1
1.8
nmol/l
1233.6
1227.1
0.03
152
684
(3004809) Band form neutrophils/100 leukocytes in Blood
43
70
6.62
25.78
3.7
3.4
%
1.4
1.5
0.05
35
59
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
91
280
3.74
25.58
2.2
1.4
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
68
169
4.49
25.58
1.6
2.7
g/l
0.3
0.7
1.09
54
148
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
261
1451
2.65
25.50
5.4
3.1
ng/l
1777.6
1250.4
1.61
232
1236
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
44
75
6.33
25.22
1.3
1.4
—
—
—
0
0
(3022313) Gas panel - Capillary blood
77
214
4.06
24.98
8.8
3.2
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
63
151
4.62
24.78
2.2
1.7
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
56
122
5.04
24.69
2.0
1.4
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
21
13
16.81
24.69
4.8
1.4
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
133
530
3.05
24.59
2.4
1.3
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
208
1058
2.64
24.05
4.4
2.2
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
226
1197
2.60
24.04
6.5
3.0
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
46
87
5.72
23.70
3.5
2.5
%
14.3
15.9
1.64
29
41
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
127
503
3.04
23.65
10.0
6.0
kpa
5.1
5.1
0.13
120
482
(3027801) Oxygen [Partial pressure] in Arterial blood
127
503
3.04
23.65
10.0
6.0
kpa
11.1
12.2
1.01
121
483
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
321
2019
2.61
23.61
7.4
3.8
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
64
162
4.38
23.47
1.6
2.3
g/l
35.3
37.2
1.57
49
137
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
36
54
7.10
23.25
1.8
1.5
%
64.0
66.3
0.12
29
38
(3021879) Hepatitis B virus core Ab [Presence] in Serum
79
237
3.77
22.94
1.5
1.3
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
125
502
2.98
22.62
10.3
6.0
mmol/l
2.0
1.3
0.81
103
400
(3019225) pH of Specimen
121
479
3.01
22.45
11.2
3.9
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
42
77
5.86
22.34
2.0
1.6
—
—
—
0
0
(3019060) Gas panel - Arterial blood
90
300
3.43
22.26
6.1
4.3
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
117
470
2.94
21.03
6.3
2.7
umol/l
14.3
8.5
0.81
105
415
(3000991) Gas panel - Venous blood
100
368
3.14
20.97
14.6
6.2
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
150
690
2.67
20.79
3.6
1.8
s
29.9
29.4
0.51
143
662
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
45
94
5.16
20.76
1.8
1.3
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
210
1136
2.45
20.63
1.8
1.6
nmol/l
22.9
21.7
0.48
180
938
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
45
95
5.10
20.51
1.6
1.6
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
36
62
6.17
20.37
2.0
1.6
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
33
52
6.72
20.34
3.2
3.6
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
42
84
5.36
20.34
1.6
1.3
mmol/l
70.0
61.8
0.39
31
71
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
57
149
4.18
19.97
1.5
2.5
g/l
0.0
0.0
0.11
51
138
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
185
957
2.47
19.92
2.4
1.6
mg/l
1.8
1.2
0.86
155
757
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
35
60
6.19
19.89
1.7
1.6
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
47
107
4.74
19.60
2.4
1.7
e6/l
34146.3
22214.9
0.31
36
74
(3021788) Differential panel - Synovial fluid
40
80
5.34
19.36
1.8
1.7
—
—
—
0
0
(3017704) Immunofixation for Urine
22
23
9.95
18.90
1.4
1.7
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
200
1094
2.37
18.79
10.0
3.5
%
91.1
90.9
0.04
195
1060
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
53
139
4.14
18.46
1.5
2.5
g/l
0.0
0.0
0.00
47
130
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
25
32
8.17
18.44
1.1
1.0
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
319
2139
2.33
18.35
7.2
4.1
estimate
0.0
0.0
0.00
100
396
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
61
178
3.76
18.32
3.5
1.8
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
291
1879
2.29
18.30
31.9
9.8
e9/l
0.0
0.0
0.43
268
1546
(3009214) Lutropin [Units/volume] in Serum or Plasma
33
58
6.02
18.28
1.2
1.3
u/l
15.3
11.5
0.40
25
46
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
46
109
4.54
18.26
1.3
1.2
u/ml
12.8
8.6
—
5
10
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
108
447
2.80
18.16
6.8
3.6
—
—
—
0
0
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
53
141
4.08
18.11
1.5
2.5
g/l
0.0
0.0
0.00
47
131
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
35
66
5.62
18.03
1.8
1.6
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
58
166
3.82
17.90
3.3
1.7
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
319
2156
2.30
17.76
9.5
5.4
estimate
0.0
0.0
0.00
101
393
(3010421) pH of Blood
46
112
4.42
17.64
6.8
3.5
ph
7.4
7.4
0.99
40
92
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
62
188
3.62
17.59
2.9
2.2
u/l
38.4
39.7
0.17
54
164
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
50
131
4.13
17.43
1.4
1.3
u/ml
7.4
2.5
—
8
20
(3009261) Glucose [Presence] in Urine by Test strip
320
2180
2.27
17.27
7.5
4.1
estimate
0.0
0.0
0.50
103
389
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
48
123
4.21
17.23
2.8
2.0
mg/l
9.8
12.5
1.21
42
115
(3012501) Base excess in Blood by calculation
41
93
4.71
17.15
6.4
3.8
mmol/l
2.9
2.7
0.10
33
62
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
50
133
4.06
17.07
1.4
1.2
u/ml
18.0
3.2
0.76
12
25
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
278
1795
2.22
17.05
7.8
3.8
ng/l
35.7
54.0
0.47
240
1329
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
27
42
6.73
16.81
1.7
1.7
—
—
—
0
0
(40758558) Short blood count panel - Blood
195
1099
2.26
16.66
15.6
7.0
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
37
79
4.97
16.62
4.1
2.6
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
39
90
4.61
15.97
1.5
1.4
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
39
90
4.61
15.97
1.5
1.4
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
25
38
6.87
15.89
1.8
1.7
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
102
438
2.66
15.82
9.5
3.2
mmol/l
2.9
2.1
1.03
83
354
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
76
279
3.03
15.79
2.1
1.7
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
50
141
3.83
15.73
1.4
1.2
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
78
294
2.95
15.46
4.8
2.9
e9/l
4.8
4.0
1.26
52
214
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
30
57
5.53
15.32
1.2
1.4
u/ml
296.5
297.5
0.00
21
30
(3006184) Hemoglobin [Mass/volume] in Capillary blood
39
94
4.41
15.13
3.0
2.2
g/l
119.5
128.8
1.33
32
69
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
23
34
7.04
14.98
1.9
1.4
%
27.0
32.5
0.29
18
23
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
25
41
6.36
14.79
1.4
1.6
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
25
41
6.36
14.79
1.4
1.6
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
25
41
6.36
14.79
1.4
1.6
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
27
48
5.89
14.76
2.6
1.7
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
16
15
10.98
14.71
2.9
6.6
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
30
60
5.25
14.49
1.2
1.3
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
280
1893
2.07
14.32
2.5
2.1
pmol/l
95.7
95.8
0.01
151
918
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
217
1340
2.08
14.16
8.6
2.9
u/l
30.5
31.2
0.18
206
1265
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
21
30
7.26
14.08
1.1
1.2
u/ml
0.1
1.5
0.48
13
15
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
30
62
5.08
13.97
2.4
1.6
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
35
84
4.40
13.64
1.2
1.4
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
79
320
2.74
13.64
1.2
1.2
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
356
2676
2.11
13.12
7.1
3.0
u/l
84.3
47.8
2.29
335
2452
(3017446) Testosterone [Moles/volume] in Serum or Plasma
57
199
3.10
12.85
2.5
2.2
nmol/l
11.0
13.3
1.42
49
178
(3004616) Nuclear Ab [Presence] in Serum
29
63
4.82
12.75
1.4
1.3
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
135
719
2.20
12.72
1.5
1.3
u/ml
28.6
12.9
1.03
51
264
(3048689) Calprotectin [Mass/mass] in Stool
104
500
2.36
12.49
4.1
2.3
ug/g
161.9
132.3
0.54
86
391
(3022217) INR in Platelet poor plasma by Coagulation assay
119
607
2.26
12.44
36.1
26.0
inr
1.4
1.2
0.48
16
74
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
32
77
4.37
12.43
1.3
1.2
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
19
28
7.01
12.38
3.6
1.4
g/l
0.9
1.1
1.12
19
28
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
37
100
3.91
12.33
1.6
1.3
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
25
49
5.32
12.33
1.3
1.4
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
30
69
4.56
12.32
1.6
1.5
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
35
92
4.01
12.12
1.5
1.2
titre
46.0
75.0
—
5
6
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
25
50
5.21
12.06
1.2
1.1
u/ml
1.4
1.3
—
9
15
(40768797) Stomach Pathology biopsy report
125
659
2.19
12.01
1.3
1.2
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
35
93
3.97
11.94
1.7
1.1
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
17
23
7.61
11.91
1.5
1.7
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
17
23
7.61
11.91
1.5
1.7
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
17
23
7.61
11.91
1.5
1.7
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
17
23
7.61
11.91
1.5
1.7
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
41
123
3.54
11.77
4.0
3.2
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
17
9
19.49
11.66
1.8
1.3
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
137
757
2.11
11.63
1.4
1.3
iu/ml
57.9
37.6
0.53
50
243
(3013512) EKG study
215
1396
1.94
11.58
6.5
4.0
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
25
52
5.01
11.55
3.4
3.5
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
37
105
3.72
11.52
1.5
1.3
—
656.0
—
0
5
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
129
702
2.12
11.37
5.8
3.0
e6/l
2.7
3.3
0.35
88
373
(3037692) Legionella sp identified in Specimen by Organism specific culture
14
16
8.97
11.16
1.7
1.4
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
18
28
6.63
11.16
1.3
1.2
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
23
46
5.19
11.09
3.6
2.2
—
—
—
0
0
(3004451) EKG impression Narrative
16
22
7.48
11.04
1.3
1.4
—
—
—
0
0
(3000492) Spirometry study
79
354
2.46
11.02
2.2
1.5
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
28
67
4.37
10.95
1.5
1.5
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
481
4228
3.79
10.89
57.6
14.8
mg/l
23.7
23.6
0.02
467
3344
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
16
9
18.31
10.79
1.9
1.3
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
14
17
8.44
10.66
1.4
1.9
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
14
17
8.44
10.66
1.4
1.9
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
181
1135
1.93
10.62
7.1
3.7
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
22
44
5.18
10.61
3.4
2.9
%
70.4
58.1
1.61
17
31
(3000093) Morphology [Interpretation] in Blood Narrative
23
48
4.97
10.58
1.3
1.2
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
18
30
6.18
10.46
1.3
1.1
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
18
30
6.18
10.46
2.6
2.3
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
14
18
7.97
10.19
1.4
1.9
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
56
220
2.74
10.19
10.0
3.1
mmol/l
25.3
24.4
0.88
51
194
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
134
767
2.02
10.18
5.6
2.7
e6/l
1.0
1.2
0.57
93
433
(40761536) Microorganisms panel - Urine sediment
77
354
2.39
10.12
7.6
4.1
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
25
59
4.41
9.95
1.2
1.1
—
—
—
0
0
(3022145) Colonoscopy Study observation
100
518
2.16
9.89
1.5
1.3
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
19
36
5.44
9.71
1.2
1.1
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
154
939
1.92
9.68
3.6
2.9
mmol/l
2.5
2.5
0.76
138
821
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
84
409
2.26
9.66
2.9
2.4
ug/l
8.2
5.7
0.41
73
356
(3008295) Osmolality of Serum or Plasma
23
52
4.59
9.64
1.3
1.4
mosm/kgh2o
270.1
275.8
0.51
16
34
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
81
392
2.27
9.44
4.0
2.3
u/l
36.0
30.8
0.47
74
319
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
23
53
4.50
9.43
1.3
1.1
u/ml
5.5
3.9
—
8
20
(44806118)
21
45
4.83
9.37
2.4
1.4
—
—
—
0
0
(44790047)
21
45
4.83
9.37
2.4
1.4
—
—
—
0
0
(44790049)
21
45
4.83
9.37
2.4
1.4
—
—
—
0
0
(44790048)
21
45
4.83
9.37
2.4
1.4
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
205
1380
1.82
9.36
4.2
3.1
mmol/l
5.6
6.8
4.84
183
1124
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
57
236
2.59
9.35
2.3
3.0
pmol/l
4.0
4.4
1.92
44
204
(3025941) Bacteria identified in Stool by Culture
58
243
2.57
9.28
1.4
1.3
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
18
34
5.45
9.22
1.6
1.1
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
16
27
6.09
9.17
2.2
1.6
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
16
27
6.09
9.17
2.3
1.6
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
16
27
6.09
9.17
1.5
1.5
u/l
27.1
12.2
—
7
14
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
22
50
4.55
9.17
1.1
1.1
u/l
56.5
49.2
0.37
17
32
(3029937) Albumin [Presence] in Urine by Test strip
184
1209
1.82
9.03
9.0
4.4
estimate
0.0
0.0
0.00
97
388
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
16
28
5.87
8.85
3.6
2.7
%
42.1
48.7
—
9
5
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
17
32
5.46
8.74
1.5
1.9
e6/l
432.7
508.8
—
7
10
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
24
61
4.08
8.70
6.5
1.7
pg
31.7
32.1
0.13
24
61
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
23
57
4.18
8.61
1.1
1.1
—
—
—
0
0
(3024263) Appearance of Synovial fluid
14
22
6.52
8.57
3.6
1.4
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
159
1016
1.82
8.45
1.8
1.7
pmol/l
490.7
456.3
0.76
136
814
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
34
112
3.18
8.44
1.0
1.1
—
9.1
—
0
12
(40768443) Skin Pathology biopsy report
49
199
2.62
8.35
1.5
1.2
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
138
850
1.86
8.23
7.1
4.0
ng/l
710.5
301.0
0.34
119
686
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
294
2251
1.73
8.22
3.4
2.6
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
28
83
3.51
8.19
2.0
1.6
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
36
127
2.98
7.97
1.6
1.6
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
12
8
15.32
7.75
1.8
1.1
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
242
1777
1.69
7.72
2.7
2.2
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
30
97
3.22
7.68
1.2
1.2
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
49
208
2.50
7.63
16.0
7.5
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
24
68
3.66
7.51
1.5
1.3
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
16
33
4.97
7.45
2.3
1.5
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
228
1667
1.67
7.26
8.4
4.3
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
17
38
4.59
7.23
2.4
1.8
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
20
51
4.04
7.23
1.4
2.5
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
24
70
3.55
7.20
1.5
1.3
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
11
16
7.01
7.17
1.0
1.1
—
—
—
0
0
(3024471) HLA-A [Type]
10
5
20.36
7.16
1.0
1.0
—
—
—
0
0
(4035726)
77
411
2.03
6.93
2.1
1.4
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
36
138
2.73
6.87
1.8
1.4
ug/g
281.2
283.7
0.03
27
81
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
44
187
2.48
6.84
2.5
2.9
u/ml
567.8
1114.2
0.28
33
158
(3016650) Hepatitis A virus Ab [Presence] in Serum
22
63
3.61
6.79
1.1
1.1
—
—
—
0
0
(4268621)
16
36
4.56
6.75
2.3
2.1
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
58
282
2.19
6.65
11.2
6.7
mmol/l
26.0
24.7
1.64
53
266
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
394
3364
1.77
6.62
5.2
4.1
pmol/l
15.4
15.0
2.16
360
3017
(40768441) Liver Pathology biopsy report
17
41
4.26
6.60
2.7
1.0
—
—
—
0
0
(4010399)
67
346
2.08
6.59
1.9
1.4
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
16
37
4.43
6.53
1.7
1.2
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
13
25
5.31
6.52
1.0
1.7
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
13
25
5.31
6.52
1.0
1.7
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
21
60
3.61
6.50
1.4
1.1
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
21
60
3.61
6.50
1.9
1.4
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
14
29
4.94
6.49
1.9
1.3
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
21
61
3.55
6.35
1.9
1.4
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
21
61
3.55
6.35
1.9
1.4
—
—
—
0
0
(3003434) Protein [Mass/volume] in Pleural fluid
18
48
3.85
6.14
1.3
1.2
g/l
25.3
31.2
0.91
18
43
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
12
23
5.32
6.03
1.2
1.1
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
12
23
5.32
6.03
2.0
1.7
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
9
6
15.23
5.92
1.2
1.3
—
—
—
0
0
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
49
235
2.20
5.81
11.2
2.3
%
0.7
0.7
0.49
49
225
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
12
24
5.10
5.77
2.1
2.2
—
—
—
0
0
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
16
41
4.00
5.75
1.1
1.1
g/l
1.7
1.5
0.88
16
34
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
442
3960
1.92
5.66
6.3
5.0
mu/l
1.9
2.3
0.66
409
3566
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
15
37
4.15
5.66
1.5
1.4
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
20
61
3.37
5.64
1.9
1.4
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
20
61
3.37
5.64
1.9
1.4
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
9
7
13.06
5.60
1.0
1.1
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
20
62
3.32
5.50
1.9
1.4
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
20
62
3.32
5.50
1.7
1.4
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
15
38
4.04
5.48
1.3
1.2
—
—
—
0
0
(3024932) HLA-DR beta [Type]
8
5
16.23
5.42
1.0
1.4
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
30
120
2.59
5.31
3.0
3.2
nmol/l
0.9
0.9
0.15
25
92
(3045414) Leukocytes [Presence] in Urine
41
190
2.26
5.29
1.6
2.0
—
—
—
0
0
(21494434) Karyotype in Bone marrow
16
44
3.72
5.24
1.1
1.1
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
87
529
1.78
5.24
3.2
3.8
ug/l
4.8
18.3
1.02
75
445
(3014271) Vancomycin [Susceptibility]
13
31
4.28
5.12
3.6
2.5
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
11
23
4.87
5.03
5.5
15.9
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
11
23
4.87
5.03
1.2
1.9
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
12
28
4.37
4.85
1.5
1.3
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
476
4424
2.28
4.80
55.7
17.4
mmol/l
138.8
139.7
8.80
469
4302
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
8
7
11.58
4.80
1.0
1.1
—
—
—
0
0
(3020891) Body temperature
40
193
2.16
4.70
11.0
4.3
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
476
4430
2.26
4.68
56.0
17.5
mmol/l
4.0
4.0
1.23
469
4304
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
19
64
3.05
4.60
1.2
1.1
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
10
21
4.84
4.55
2.1
1.3
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
8
276
0.28
4.54
1.6
1.7
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
25
99
2.60
4.53
1.8
1.6
iu/l
3.4
6.4
—
8
30
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
21
77
2.80
4.40
2.0
2.5
mg/l
38.2
25.6
—
5
20
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
13
35
3.79
4.39
1.2
1.2
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
13
35
3.79
4.39
1.2
1.2
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
13
35
3.79
4.39
1.2
1.2
—
—
—
0
0
(3003129) Base excess in Capillary blood by calculation
9
12
7.61
4.37
2.4
1.2
mmol/l
2.4
2.3
—
9
12
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
440
4012
1.74
4.29
43.3
14.2
ml/min/173m2
74.2
76.3
1.08
411
3302
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
12
31
3.94
4.28
1.8
1.1
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
16
51
3.21
4.24
1.3
1.3
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
47
251
1.96
4.24
2.4
2.4
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
13
36
3.68
4.23
1.2
1.2
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
13
36
3.68
4.23
1.2
1.2
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
13
36
3.68
4.23
1.2
1.2
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
480
4508
2.26
4.16
31.9
10.9
u/l
26.0
24.5
0.86
473
4326
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
13
37
3.58
4.07
1.2
1.1
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
14
42
3.40
4.07
1.4
1.5
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
469
4374
1.99
4.04
45.5
14.2
—
—
—
0
0
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
11
28
3.99
3.99
1.2
1.1
mmol/l
2.0
1.9
0.25
11
28
(3024928) Oxygen saturation in Venous blood
25
106
2.43
3.97
13.6
2.3
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
15
48
3.19
3.96
1.1
1.1
—
—
—
0
0
(4306422)
14
43
3.32
3.93
1.1
1.2
—
—
—
0
0
(3048879) Bone marrow aspiration report
8
11
7.37
3.87
1.5
2.7
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
9
15
6.09
3.83
1.9
1.3
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
7
8
8.85
3.78
3.1
1.4
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
6
5
12.12
3.77
1.0
1.2
—
—
—
0
0
(3013727) Leukocytes other/100 leukocytes in Blood
9
16
5.71
3.67
5.3
4.3
%
54.4
48.2
—
9
16
(40761535) Cells panel - Urine sediment
65
405
1.69
3.58
7.2
3.5
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
7
9
7.87
3.57
1.7
1.2
—
—
—
0
0
(3011436) Histone Ab [Units/volume] in Serum
6
6
10.10
3.50
1.2
1.2
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
6
6
10.10
3.50
1.2
2.2
—
—
—
0
0
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
6
6
10.10
3.50
1.2
2.2
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
11
31
3.61
3.50
1.5
1.2
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
12
36
3.39
3.49
1.2
1.0
—
—
—
0
0
(4015189)
7
10
7.08
3.37
4.7
2.6
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
7
10
7.08
3.37
1.0
1.0
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
7
10
7.08
3.37
1.3
1.3
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
8
14
5.79
3.35
1.1
1.1
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
8
14
5.79
3.35
1.1
1.1
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
8
14
5.79
3.35
1.1
1.1
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
11
32
3.49
3.35
2.8
3.4
—
—
—
0
0
(3000012) Reticulocyte production index
11
32
3.49
3.35
1.4
1.5
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
5
189
0.26
3.31
1.4
1.4
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
13
43
3.08
3.27
6.5
2.8
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
45
264
1.77
3.08
1.4
1.4
—
42.4
—
0
17
(3009871) Measles virus Ab [Titer] in Serum
6
8
7.57
3.06
1.8
1.6
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
6
8
7.57
3.06
2.2
1.5
—
—
—
0
0
(3034426) Prothrombin time (PT)
6
8
7.57
3.06
1.0
1.1
—
—
—
0
0
(3039000) Anion gap in Blood
20
87
2.35
3.04
10.5
6.4
mmol/l
10.3
11.0
0.65
20
80
(3018572) Chloride [Moles/volume] in Blood
20
87
2.35
3.04
10.6
6.4
mmol/l
105.2
104.8
0.15
20
80
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
9
21
4.34
3.00
1.3
1.1
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
5
5
10.08
2.98
1.6
2.2
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
5
5
10.08
2.98
1.6
2.2
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
83
577
1.52
2.93
1.4
1.4
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
25
122
2.10
2.92
1.2
1.3
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
7
13
5.44
2.87
2.4
1.8
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
18
78
2.36
2.77
18.2
1.6
%
64.1
57.6
0.53
18
78
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
5
6
8.40
2.75
1.2
1.0
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
5
6
8.40
2.75
1.0
1.2
—
—
—
0
0
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
5
6
8.40
2.75
1.0
1.2
%
107.4
107.5
—
5
6
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
48
297
1.68
2.74
2.7
2.6
—
15.3
—
0
12
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
7
14
5.05
2.73
2.0
2.5
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
11
37
3.02
2.70
2.4
1.1
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
8
19
4.26
2.69
1.0
1.1
iu/ml
877.8
115.4
—
8
19
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
9
24
3.80
2.68
1.4
1.1
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
9
24
3.80
2.68
1.4
1.1
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
404
3718
1.43
2.66
46.2
15.9
%
36.6
39.2
4.58
227
2462
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
7
15
4.72
2.60
1.0
1.1
ug/l
11.7
9.4
—
7
15
(3010813) Leukocytes [#/volume] in Blood
483
4630
1.95
2.59
74.2
22.3
e9/l
7.8
6.7
15.58
475
4481
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
432
4031
1.49
2.59
7.0
6.3
mmol/mol
39.7
40.2
0.51
388
3700
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
58
383
1.58
2.58
2.7
1.7
%
1.6
1.5
0.16
51
335
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
8
20
4.05
2.57
1.0
1.1
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
85
611
1.47
2.56
4.4
4.7
%
36.2
32.6
2.06
65
381
(3018851) Theophylline [Moles/volume] in Serum or Plasma
5
7
7.20
2.55
2.0
1.4
umol/l
39.6
42.7
—
5
7
(3008536) Aspergillus sp Ab [Presence] in Serum
6
11
5.50
2.55
1.0
1.3
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
56
370
1.58
2.49
3.3
2.7
ml/min/173m2
55.4
62.4
0.54
32
162
(3035880) pH of Pleural fluid
8
21
3.85
2.47
1.0
1.1
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
12
45
2.71
2.46
1.1
1.3
pmol/l
437.2
270.4
—
6
34
(40761539) Cells [Type] in Urine sediment by Light microscopy
6
12
5.05
2.41
1.0
1.1
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
482
4628
1.87
2.40
74.2
22.3
e9/l
259.9
249.8
1.99
476
4501
(3024731) MCV [Entitic volume]
482
4628
1.87
2.40
73.7
22.3
fl
92.9
91.3
8.03
476
4547
(3035941) MCH [Entitic mass]
482
4629
1.87
2.39
73.6
22.2
pg
30.3
30.3
0.04
476
4547
(3026361) Erythrocytes [#/volume] in Blood
482
4629
1.87
2.39
74.1
22.3
e12/l
4.1
4.4
28.70
476
4481
(3000963) Hemoglobin [Mass/volume] in Blood
482
4629
1.87
2.39
74.7
22.4
g/l
123.6
133.3
34.38
477
4544
(3017817) Protein [Mass] in Urine collected for unspecified duration
11
40
2.79
2.39
2.1
2.6
—
—
—
0
0
(4024509)
11
40
2.79
2.39
1.3
1.3
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
173
1423
1.33
2.33
4.7
3.9
mg/mmol
31.2
7.0
1.97
111
845
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
5
9
5.60
2.22
1.0
1.2
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
17
80
2.16
2.21
2.7
1.2
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
12
266
0.44
2.20
1.3
1.4
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
7
19
3.72
2.15
1.1
1.1
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
6
14
4.32
2.15
2.5
1.5
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
6
14
4.32
2.15
1.0
1.0
miu/ml
1404.3
1567.0
—
6
14
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
21
110
1.95
2.08
2.4
1.2
mg/l
1743.4
523.0
0.50
21
103
(3013293) Extractable nuclear Ab [Presence] in Serum
5
10
5.04
2.07
1.2
1.6
—
—
—
0
0
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
6
15
4.03
2.04
2.7
1.7
umol/l
56.8
53.0
—
6
10
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
9
32
2.84
2.01
1.9
1.3
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
162
1345
1.30
1.99
4.1
3.2
mg/l
662.3
234.9
0.53
112
801
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
7
21
3.36
1.97
1.4
1.1
—
—
—
0
0
(3002256) Pathology report gross observation
74
550
1.40
1.88
1.3
1.3
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
0
53
0.00
1.88
0.0
1.4
—
—
—
0
0
(3011648) Oxygen content in Venous blood
9
34
2.68
1.87
1.2
1.5
%
11.6
10.4
—
9
34
(42529582) MDA5 Ab [Presence] in Serum by Line blot
5
12
4.20
1.82
1.0
1.0
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
5
12
4.20
1.82
1.0
1.0
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
5
12
4.20
1.82
1.0
1.0
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
5
12
4.20
1.82
1.0
1.0
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
128
1041
1.31
1.82
7.8
4.1
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
9
35
2.60
1.81
2.1
1.2
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
9
35
2.60
1.81
2.1
1.2
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
27
162
1.70
1.78
2.1
2.7
—
—
—
0
0
(4027681)
7
24
2.94
1.73
1.1
1.1
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
7
25
2.82
1.65
1.3
1.7
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
17
91
1.90
1.62
1.1
1.4
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
5
14
3.60
1.62
1.4
1.2
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
5
14
3.60
1.62
1.0
1.1
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
6
20
3.02
1.58
1.0
1.1
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
111
1345
0.78
1.57
2.9
3.1
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
25
153
1.67
1.56
1.3
1.5
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
10
44
2.30
1.54
1.1
1.1
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
7
27
2.61
1.52
1.3
1.0
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
6
21
2.88
1.51
1.7
1.1
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
6
21
2.88
1.51
1.7
1.1
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
24
147
1.66
1.50
1.2
1.1
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
10
45
2.25
1.47
1.2
1.0
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
24
148
1.65
1.47
1.3
1.1
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
7
28
2.52
1.45
8.3
2.9
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
7
153
0.45
1.45
1.3
1.7
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
6
22
2.75
1.44
1.3
1.2
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
24
150
1.63
1.40
1.3
1.2
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
14
74
1.92
1.40
1.6
1.6
—
—
—
0
0
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
0
38
0.00
1.35
0.0
1.0
—
617.9
—
0
23
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
0
38
0.00
1.35
0.0
1.0
—
293.4
—
0
22
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
0
38
0.00
1.35
0.0
1.0
—
41.8
—
0
22
(3005570) Glucose [Moles/volume] in Urine
10
47
2.15
1.34
1.2
2.7
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
13
68
1.94
1.34
3.0
2.4
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
6
24
2.52
1.30
1.2
2.0
—
—
—
0
0
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
8
34
2.37
1.29
1.5
1.4
—
62.0
—
0
5
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
6
134
0.44
1.29
3.8
1.9
mg/l
4.2
2.1
—
6
103
(40768795) Lymph node Pathology biopsy report
9
44
2.06
1.27
1.8
1.2
—
—
—
0
0
(3022621) pH of Urine by Test strip
41
300
1.40
1.19
6.2
2.9
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
7
30
2.35
1.12
1.9
2.2
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
435
4195
1.26
1.04
5.1
4.9
mmol/l
5.6
6.0
8.47
391
3785
(3028707) Methadone [Presence] in Urine by Screen method
7
35
2.01
1.00
1.3
1.3
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
7
35
2.01
1.00
1.3
1.0
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
0
32
0.00
0.95
0.0
1.5
—
—
—
0
0
(40768793) Breast Pathology biopsy report
8
145
0.54
0.94
1.4
1.3
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
6
27
2.24
0.93
1.0
1.2
—
—
—
0
0
(3019420) Tryptase [Mass/volume] in Serum or Plasma
6
28
2.16
0.91
2.2
1.3
ug/l
11.4
6.5
—
6
23
(3051387) C reactive protein [Mass/volume] in Capillary blood
15
95
1.60
0.88
7.9
3.9
mg/l
36.8
34.1
—
9
52
(3047007) Chlamydophila sp Ab [Presence] in Serum
8
43
1.87
0.87
1.4
1.2
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
8
43
1.87
0.87
4.3
1.3
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
15
97
1.56
0.82
1.1
1.1
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
8
48
1.68
0.79
1.3
1.1
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
14
90
1.57
0.79
1.7
1.6
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
23
166
1.40
0.77
1.7
1.5
—
—
—
0
0
(3044889) 12 lead EKG panel
327
3108
1.15
0.76
5.9
4.1
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
11
67
1.66
0.75
1.3
1.2
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
110
974
1.17
0.71
9.2
4.5
kg/l
1.0
1.0
1.18
22
128
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
34
266
1.30
0.70
1.1
1.2
iu/ml
30.6
127.8
4.78
11
104
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
9
58
1.56
0.70
1.0
1.1
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
11
69
1.61
0.69
1.3
1.2
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
11
69
1.61
0.69
1.3
1.2
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
5
27
1.86
0.68
1.8
1.9
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
7
43
1.64
0.67
1.4
1.0
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
32
402
0.78
0.64
1.6
1.5
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
431
4201
1.18
0.62
4.8
4.7
mmol/l
4.6
4.7
0.51
384
3831
(3043409) Potassium [Moles/volume] in Arterial blood
20
152
1.33
0.53
10.1
3.8
mmol/l
3.8
3.9
0.53
20
143
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
9
132
0.68
0.52
1.9
1.3
—
—
—
0
0
(3008898) HLA-B27 [Presence]
17
126
1.36
0.52
1.2
1.1
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
427
4173
1.15
0.51
4.8
4.7
mmol/l
1.6
1.5
1.19
380
3780
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
413
4028
1.14
0.51
4.5
4.2
mmol/l
1.4
1.3
2.10
363
3623
(4034850)
20
153
1.32
0.51
21.9
11.2
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
10
67
1.50
0.50
1.3
1.2
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
439
4304
1.15
0.47
5.2
5.4
mmol/l
2.6
2.7
2.66
394
3900
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
102
928
1.12
0.46
5.1
5.2
ug/l
2.3
2.6
0.13
87
826
(1761482) Bacteria [#/volume] in Urine by Culture
17
130
1.32
0.44
7.1
4.9
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
112
1028
1.11
0.44
1.4
1.3
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
5
31
1.62
0.43
1.0
1.0
—
0.7
—
0
15
(44816559) Phosphatidylethanol [Mass/volume] in Blood
10
70
1.44
0.42
1.2
1.1
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
5
33
1.52
0.41
1.2
1.4
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma
0
16
0.00
0.41
0.0
2.3
—
2.1
—
0
7
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
18
227
0.79
0.41
2.0
1.8
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
48
548
0.86
0.41
2.6
3.0
ug/l
0.5
0.8
2.70
33
367
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
0
18
0.00
0.40
0.0
1.1
—
1.5
—
0
5
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
0
18
0.00
0.40
0.0
1.5
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
67
744
0.89
0.39
4.2
4.6
%
21.0
20.9
0.02
30
371
(4094501)
8
116
0.68
0.37
1.4
1.1
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
6
43
1.40
0.35
1.5
1.3
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
6
43
1.40
0.35
1.5
1.0
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
14
109
1.29
0.34
2.6
1.6
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
7
52
1.35
0.31
1.1
1.2
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
17
206
0.82
0.29
1.9
1.7
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
24
204
1.19
0.29
1.3
1.3
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
8
64
1.25
0.27
1.3
1.2
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
32
285
1.13
0.23
1.2
1.3
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
24
212
1.14
0.20
1.1
1.0
—
—
—
0
0
(4281824)
6
51
1.18
0.19
1.7
1.1
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
22
248
0.88
0.18
1.2
1.3
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
7
58
1.21
0.18
2.0
1.5
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
61
646
0.94
0.16
1.4
1.4
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
9
103
0.87
0.06
1.8
2.4
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
25
240
1.04
0.03
6.2
3.8
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
62
609
1.02
0.03
12.7
7.8
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
118
1191
0.99
0.02
1.5
1.6
mmol/l
1.5
1.3
1.01
106
983
(3008116) Ketones [Moles/volume] in Urine by Test strip
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.3
—
1.9
—
0
6
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
5
55
0.91
0.00
1.0
1.3
—
—
—
0
0
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
0
6
0.00
0.00
0.0
1.3
—
0.7
—
0
6
(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
25.8
—
0
5
(3027300) Silver Birch IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
9
89
1.01
0.00
1.6
1.4
nmol/l
1.0
0.9
—
9
71
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
5
59
0.85
0.00
1.0
1.3
nmol/l
0.7
0.6
—
5
54
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0

Mortality – FinRegistry

↥

Association

Association between endpoint OSTPOPATFRACTURE and mortality.

Females

Parameter HR [95% CI] p-value
OSTPOPATFRACTURE 2.879 [2.39, 3.46] < 0.001
Birth year 0.996 [0.99, 1.01] 0.421

During the follow-up period (1.1.1998 — 31.12.2019), 572 out of 1455 females with OSTPOPATFRACTURE died.

Males

Parameter HR [95% CI] p-value
OSTPOPATFRACTURE 4.177 [3.06, 5.7] < 0.001
Birth year 0.991 [0.98, 1.0] 0.09

During the follow-up period (1.1.1998 — 31.12.2019), 329 out of 649 males with OSTPOPATFRACTURE died.

Mortality risk

Mortality risk for people of age

years, who have OSTPOPATFRACTURE.

N-year risk Females Males
1 0.297% 0.753%
5 1.672% 4.626%
10 3.99% 12.785%
15 7.552% 23.481%
20 14.115% 37.703%

Relationships between endpoints

↥

Index endpoint: OSTPOPATFRACTURE – Drug-induced osteoporosis with pathological fracture

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data